Quantum BioPharma Ltd. (QNTM) NASDAQ
3.47
-0.06(-1.70%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.47
-0.06(-1.70%)
Currency In USD
| Previous Close | 3.53 |
| Open | 3.51 |
| Day High | 3.68 |
| Day Low | 3.45 |
| 52-Week High | 38.25 |
| 52-Week Low | 2.07 |
| Volume | 27,202.8 |
| Average Volume | 311,400 |
| Market Cap | 14.27M |
| PE | -0.42 |
| EPS | -8.2 |
| Moving Average 50 Days | 3.63 |
| Moving Average 200 Days | 11.75 |
| Change | -0.06 |
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
Newsfile
Dec 11, 2025 1:00 AM GMT
Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biot
Quantum BioPharma Ltd. Announces Corporate Updates
Newsfile
Oct 30, 2025 1:00 AM GMT
Toronto, Ontario--(Newsfile Corp. - October 29, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative
Quantum BioPharma Announces Corporate Updates
Newsfile
Sep 27, 2025 12:00 AM GMT
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovati